Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patients
2003 ◽
Vol 107
(2)
◽
pp. 81-86
◽
1991 ◽
Vol 24
(7)
◽
pp. 2097-2097
2015 ◽
Vol 5
(3)
◽
pp. 134-142
Keyword(s):
2003 ◽
Vol 70
(5)
◽
pp. 282-289
◽